SPONSOR
Recursion Pharmaceuticals Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Recursion Pharmaceuticals Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Unresectable, Locally Advanced, Metastatic Cancers, Relapsed/Refractory Lymphomas.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Recursion Pharmaceuticals Inc.
How many clinical trials has Recursion Pharmaceuticals Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Recursion Pharmaceuticals Inc., of which 1 are actively recruiting participants. These trials cover conditions including Unresectable, Locally Advanced, Metastatic Cancers. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Recursion Pharmaceuticals Inc. research focus on?
Recursion Pharmaceuticals Inc. clinical trials span Unresectable, Locally Advanced, Metastatic Cancers, Relapsed/Refractory Lymphomas. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Recursion Pharmaceuticals Inc. clinical trial?
To participate in a Recursion Pharmaceuticals Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Recursion Pharmaceuticals Inc. trials with current recruitment status updated daily.
Clinical Trials by Recursion Pharmaceuticals Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology